Sponsored
Article Tools

Semperit AG Holding / Impairment of approx. EUR 26 million in Sempermed segment

Published: July 27, 2017; 14:41 · (Vindobona)

Following an in-depth review, the Management Board of Semperit AG Holding has come to the conclusion today that the sustainably achievable production volume at the site in Kamunting, Malaysia, is lower than previously assumed. As a result, an impairment of approximately EUR 26 million has to be recognised in the interim consolidated financial statements as of 30 June 2017. Thus, based on current knowledge, the goodwill of the segment will be completely impaired.

Semperit AG Holding / Impairment of approx. EUR 26 million in Sempermed segment / Picture: © Vindobona

Disclosed inside information pursuant to article 17 Market Abuse Regulation (MAR) transmitted by euro adhoc with the aim of a Europewide distribution. The issuer is responsible for the content of this announcement.

Company Information
27.07.2017

Vienna - On 10 April 2017, Semperit AG Holding announced in accordance with
Article 17 of the EU Market Abuse…

This article includes a total of 335 words.

or Log In